KaydedilenlerDerginizi ekleyin

Dergiler / Türk Geriatri Dergisi / 2021 / Cilt: 24 - Sayı: 1

IS POSTHERPETIC NEURALGIA AN INEVITABLE END IN ELDERLY CASES WITH HERPES ZOSTER? AN EVALUATION OF AGE-RELATED RISK FACTORS IN THE DEVELOPMENT OF POSTHERPETIC NEURALGIA

Damla YÜRÜK
Ayçin YILDIZ TABAKOĞLU
Sayfa
41–49
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Special protection, follow-up and treatment is needed to prevent the development of PHN in HZ cases over 65 years of age, especially those with sacral and trigeminal dermatomes and presence of chronic disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: The aim of this study is to evaluate the risk factors in the development of postherpetic neuralgia (PHN) in cases with herpes zoster (HZ) over 65 and under 65 years of age.
📊
Temel Bulgular & Veri:Methods: 90 cases with a diagnosis of HZ were divided into 2 groups as over 65 and under 65 years of age. 3 months after the onset of the rash, those with VAS score> 3 were considered as cases who developed PHN.
💡
Sonuç & Katkı:Conclusion: Special protection, follow-up and treatment is needed to prevent the development of PHN in HZ cases over 65 years of age, especially those with sacral and trigeminal dermatomes and presence of chronic disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Introduction: The aim of this study is to evaluate the risk factors in the development of postherpetic neuralgia (PHN) in cases with herpes zoster (HZ) over 65 and under 65 years of age. Methods: 90 cases with a diagnosis of HZ were divided into 2 groups as over 65 and under 65 years of age. 3 months after the onset of the rash, those with VAS score> 3 were considered as cases who developed PHN. The demographic and clinical data of the cases were compared statistically. Results: In 90 HZ cases; the number of HZ cases over the age of 65 was 38 (42,2%), and the number of HZ cases under the age of 65 was 52 (57,7%). PHN developed in 53 (58.8%) of 90 HZ cases. While the initial VAS score (p 0.05) (p>0,05) were not found significant. Also in the HZ cases over 65 years of age, the affected dermatome (p <0.05) and in the HZ cases under 65 years of age, gender (p=0,05) was found significant in the development of PHN. Conclusion: Special protection, follow-up and treatment is needed to prevent the development of PHN in HZ cases over 65 years of age, especially those with sacral and trigeminal dermatomes and presence of chronic disease.

🔖

Bu Makaleye Atıf Yap

YÜRÜK, D., TABAKOĞLU, A. Y. (2021). IS POSTHERPETIC NEURALGIA AN INEVITABLE END IN ELDERLY CASES WITH HERPES ZOSTER? AN EVALUATION OF AGE-RELATED RISK FACTORS IN THE DEVELOPMENT OF POSTHERPETIC NEURALGIA. Türk Geriatri Dergisi, Cilt: 24 - Sayı: 1, 41–49. https://ajindex.com/articles/402107

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Al-Turab M, Chehadeh W. Varicella infection in the Middle East: Prevalence, complications, and vaccination. J Res Med Sci. 2018 Apr 26;23:19. (PMID: 29887897
  2. Watanabe D. [Cutaneous Herpesvirus Infection]. Brain Nerve. 2019 Apr;71(4):302-308. ( PMID: 30988211
  3. Chapman RS, Cross KW, Fleming DM. The incidence of shingles and its implications for vaccination policy. Vaccine 2003; 21(19-20):2541-7.(PMID: 12744889
  4. Friesen KJ, Chateau D, Falk J, Alessi-Severini S, Bugden S. Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect Dis. 2017 Jan 13;17(1):69. (PMID: 28086817
  5. Weaver BA. The burden of herpes zoster and postherpetic neuralgia in the United States.J AmOsteopathAssoc2007;107(3 ):2-7. (PMID: 17488884
  6. Johnson RW, Bouhassira D,Kassianos G, Leplege A, Schmader KE,Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8:37. (PMID: 20565946
  7. Inata K, Miyazaki D, Uotani R et.al. Effectiveness of real-time PCR for diagnosis and prognosis of varicella-zoster virus keratitis. Jpn J Ophthalmol. 2018 Jul;62(4):425-431. (PMID: 29948430
  8. Gross GE, Eisert L, Doerr HW et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. J Dtsch Dermatol Ges 2020;18(1):55-78. (PMID: 31951098
  9. Reid MC, Pillemer K.Management of chronic pain in older adults. BMJ 2015; 350:532. (PMID: 25680884
  10. Zhou J, Li J, Ma L, Cao S. Zoster sine herpete: a review. Korean J Pain. 2020 Jul 1;33(3):208-215. ( PMID: 32606265
  11. Dworkin RH, Perkins FM, Nagasako EM: Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain 2000;16: 90-100. (PMID: 10870747
  12. Jung BF, Johnson RW, Griffin DR, Dworkin RH: Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62(9):1545-1551. (PMID: 15136679
  13. Harpaz R, Nagel MA, Schmader K, Tyring SK, Yawn BP. Roundtable on postherpetic neuralgia– what,why,how long,and what’s next? Popul Health Manag2012;15(6):385-90. (PMID: 23088665
  14. Forbes HJ, Thomas SL, Smeeth L et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain 2016; 157(1):30-54. (PMID: 26218719
  15. Baron R, Haendler G, Schulte H. Afferent large fiber polyneuropathy predicts development of postherpetic neuralgia. Pain 1997;73(2):231-8.(PMID: 9415510
  16. Coen PG, Scott F, Leedham-Green M et al.Predicting and pr